Moorman, P. G., Sesay, J., Nwosu, V., Kane, J. G., de Cotret, A. R., Worley, K., & Millikan, R. (2005). Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women. Cancer Epidemiol Biomarkers Prev, 14(12), 3013–3014. https://doi.org/10.1158/1055-9965.EPI-05-0291

Moorman, Patricia G., John Sesay, Veronica Nwosu, Janet Grubber Kane, Allan René de Cotret, Kendra Worley, and Robert Millikan. “Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.” Cancer Epidemiol Biomarkers Prev 14, no. 12 (December 2005): 3013–14. https://doi.org/10.1158/1055-9965.EPI-05-0291.

Moorman PG, Sesay J, Nwosu V, Kane JG, de Cotret AR, Worley K, et al. Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women. Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3013–4.

Moorman, Patricia G., et al. “Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.” Cancer Epidemiol Biomarkers Prev, vol. 14, no. 12, Dec. 2005, pp. 3013–14. Pubmed, doi:10.1158/1055-9965.EPI-05-0291.

Moorman PG, Sesay J, Nwosu V, Kane JG, de Cotret AR, Worley K, Millikan R. Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women. Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3013–3014.